Elevance Health (ELV) Non Operating Interest Expenses (2009 - 2026)

Elevance Health (ELV) has reported Non Operating Interest Expenses for 18 consecutive years, with $364.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 6.74% year-over-year to $364.0 million in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 8.53% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 18.31% from the prior year.
• Non Operating Interest Expenses was $364.0 million for Q2 2026 at Elevance Health, up from $357.0 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $366.0 million in Q4 2025 and troughed at $201.0 million in Q1 2022.
• A 5-year average of $288.3 million and a median of $272.5 million in 2024 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses climbed 1.46% in 2022 and jumped 31.27% in 2024, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $229.0 million in 2022, then climbed by 13.1% to $259.0 million in 2023, then soared by 31.27% to $340.0 million in 2024, then rose by 7.65% to $366.0 million in 2025, then declined by 0.55% to $364.0 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $364.0 million (Q2 2026), $357.0 million (Q1 2026), and $366.0 million (Q4 2025), per Business Quant data.